Behavioural and functional characterization of K sub(v)10.1 (Eag1) knockout mice
K sub(v)10.1 (Eag1), member of the K sub(v)10 family of voltage-gated potassium channels, is preferentially expressed in adult brain. The aim of the present study was to unravel the functional role of K sub(v)10.1 in the brain by generating knockout mice, where the voltage sensor and pore region of...
Gespeichert in:
Veröffentlicht in: | Human molecular genetics 2013-06, Vol.22 (11), p.2247-2262 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | K sub(v)10.1 (Eag1), member of the K sub(v)10 family of voltage-gated potassium channels, is preferentially expressed in adult brain. The aim of the present study was to unravel the functional role of K sub(v)10.1 in the brain by generating knockout mice, where the voltage sensor and pore region of K sub(v)10.1 were removed to render non-functional proteins through deletion of exon 7 of the KCNH1 gene using the '3 Lox P strategy'. K sub(v)10.1-deficient mice show no obvious alterations during embryogenesis and develop normally to adulthood; cortex, hippocampus and cerebellum appear anatomically normal. Other tests, including general health screen, sensorimotor functioning and gating, anxiety, social behaviour, learning and memory did not show any functional aberrations in K sub(v)10.1 null mice. K sub(v)10.1 null mice display mild hyperactivity and longer-lasting haloperidol-induced catalepsy, but there was no difference between genotypes in amphetamine sensitization and withdrawal, reactivity to apomorphine and haloperidol in the prepulse inhibition tests or to antidepressants in the haloperidol-induced catalepsy. Furthermore, electrical properties of K sub(v)10.1 in cerebellar Purkinje cells did not show any difference between genotypes. Bearing in mind that K sub(v)10.1 is overexpressed in over 70% of all human tumours and that its inhibition leads to a reduced tumour cell proliferation, the fact that deletion of K sub(v)10.1 does not show a marked phenotype is a prerequisite for utilizing K sub(v)10.1 blocking and/or reduction techniques, such as siRNA, to treat cancer. |
---|---|
ISSN: | 0964-6906 1460-2083 |
DOI: | 10.1093/hmg/ddt076 |